Global Apheresis Market Report and Forecast 2032

Apheresis Market Insights & Analysis

The Global Apheresis Market is anticipated to register a CAGR of around 6.60% during the forecast period, i.e., 2025-32. Also, the market size was valued at nearly USD 5.4 billion in 2032. The market size is been driven by the upgrade in the prevalence of chronic illnesses & technological developments in the healthcare industry. As apheresis aids in blood filtration & purification, it is utilized in several medical procedures, such as rheumatoid arthritis, cancer treatment, kidney disorders, and diabetes. Additionally, the industry is expanding due to the surge in the frequency of cardiovascular disorders among the elderly population. To achieve optimal outcomes, Apheresis Market companies are expanding their product portfolios by introducing new products with cutting-edge technologies. Further, in order to match consumer expectations & expand their brands globally, they are entering into business relationships. Businesses in this sector concentrate on R&D to create innovative medical supplies for apheresis operations.

Global Apheresis Market FY32

• Study Period: 2020- 2032


• Base Year: 2024


• CAGR(2025-2032): 6.60%


• Market Value 2032: USD 5.4 Billion


• Fastest Growing Market: North America


• Major Players: B. Braun SE, Asahi Kasei Corporation, Fresenius SE & Co. KgaA, Haemonetics Corporation, Terumo Corporation, KANEKA CORPORATION, SB-KAWASUMI LABORATORIES, and Others 

A medical treatment called apheresis is employed to remove one or more blood components from a patient and put the remaining blood back into circulation. It is sometimes referred to as hemapheresis or pheresis. White blood cells, platelets, plasma, and stem cells can all be extracted using apheresis and used in medical procedures. Blood must first be drawn from a donor, then the remaining blood must be transfused back into the donor after being separated into its constituent components by a centrifuge. Also, developments in automated apheresis systems are utilized in CAR-T cell therapies, cell & gene therapies, sickle cell diseases, and symptom management. To enhance patient outcomes, these systems are employed in therapeutic interventions & the creation of cell-based therapeutics.

Moreover, one of the major drivers propelling the industry is the increasing need for apheresis to treat various illnesses, like cardiac neonatal lupus, autoimmune hemolytic anemia, and acute disseminated encephalomyelitis. In addition, apheresis is being employed more often worldwide to get plasma for the treatment of burn & trauma patients. This adds to the industry growth, as does the rapidly expanding healthcare sector. The market is also positively impacted by rising investments made by major industry participants in R&D to create a better blood purifying system that treats severe cases of arteriosclerosis obliterans.

Furthermore, market investors are being presented with portfolio expansion prospects owing to the increasing need for source plasma to treat hemophilia & primary immunodeficiency. Additionally, a promising market outlook is being provided by the surging usage of apheresis as a treatment for several illnesses, such as fulminant hepatic failure, autoimmune disease, hemolytic uremic syndrome, drug toxicities, thrombotic thrombocytopenic purpura, and sepsis. Further, the general public’s growing awareness of the advantages of apheresis will enhance the Global Apheresis Market share in the coming years.

Apheresis Market Dynamics

• Growing Issues of Chronic Disorders to Drive Market Growth

Chronic diseases like chronic obstructive pulmonary disease, chronic renal disease, asthma, and diabetes are being caused by changing lifestyles, a lack of physical activity, and poor diet. Apheresis ensures appropriate blood filtration, which can improve a patient’s quality of life even though treatment does not cure certain disorders. Glomerulonephritis, a collection of kidney disorders marked by glomerulus inflammation, responds well to apheresis treatment. Apheresis aids in maintaining kidney function by eliminating dangerous antibodies & immune complexes. Therefore, the Apheresis Market statistics for apheresis are being supported by the surge in the prevalence of chronic illnesses.

Moreover, an estimated 17.9 million NCD fatalities each year are attributed to cardiovascular illnesses, with malignancies coming in second with nearly 9.3 million, chronic respiratory diseases with about 4.1 million, and diabetes with around 2.0 million deaths from renal disease due to diabetes. Hence, the Apheresis Market is rising as a result of the upscale in the occurrence of these conditions.

• Shortage of Trained Specialists Might Hinder the Growth of the Market

The Apheresis Market is facing several challenges, which could unintentionally limit growth opportunities even despite the introduction of new revenue streams. The shortage of qualified personnel is a major impediment to growth. A historic level of technical advancement has occurred recently, revolutionizing the healthcare sector and its operations in the process. Still, the lack of skilled operators drives up the expense of acquiring knowledgeable resources, driving up the already high cost of apheresis treatments.

Moreover, government initiatives and reimbursement programs aid in alleviating healthcare costs in developed regions like North America & Europe. Cost issues in emerging & impoverished areas, however, may limit the prospects available to market participants, even though these are extremely profitable but mostly unexplored sectors.

• Progressions in Apheresis Technology to Open New Doors for the Industry

Apheresis device technological development, like automation, better safety measures, and improved separation techniques, are speeding up, improving safety measures, and improved separation techniques, are speeding up, improving safety, and streamlining procedures. Adoption is being fueled by these developments as they are minimizing the hazards related to apheresis, shortening the duration of the process, and increasing patient outcomes. Home-based therapies & other treatments outside of the hospital are also made possible by the advancement of portable & easier-to-use apheresis equipment. By making therapy more accessible, these devices broaden the market & give patients flexibility, particularly those who require regular or long-term apheresis.

Apheresis Market Segment-wise Analysis

By Product:

• Apheresis Devices
• Disposables

The Apheresis Devices is anticipated to capture the largest share of the Apheresis Market. The centrifugation apheresis device & membrane separators are the two sub-segments that make up the apheresis device segment. Due to many significant advantages, it provides over-membrane separation technology, the centrifugation Apheresis Device Market in 2023. Healthcare professionals looking for comprehensive treatment options for a range of conditions, including leukemia, autoimmune disorders, and neurological diseases, highly value centrifugation apheresis devices due to their high efficiency in separating blood components, which makes them a preferred choice for therapeutic procedures. Due to the growing use of centrifugation apheresis equipment in hospitals, this is propelling the market segment’s expansion.

By Distribution Channel:

• Blood Collection Centers & Blood Component Providers
• Hospitals & Transfusion Centers
• Others

Due to the growing demand for apheresis machines & related disposables, Blood Collection Centers & Blood Component Providers held the largest share of the Apheresis Market. Through the collection, distribution, and processing of blood products to patients experiencing numerous medical surgeries, transfusions, and treatments, blood collection centers & blood component providers play a major role in the healthcare ecosystem.

With the surging demand for blood components like plasma, red blood cells, and platelets, these facilities need to have the most current apheresis technologies to collect & separate these components from whole blood donations in an effective manner. Consequently, during the forecast period, the Apheresis Industry is presumed to expand at a faster rate owing to the enhanced demand from blood-collecting facilities & suppliers of blood components.

Regional Projection of the Apheresis Industry

The Global Apheresis Market is geographically diversified, covering:

• North America
• Europe
• South America
• The Middle East & Africa
• Asia-Pacific

Geographically, North America dominates the Global Apheresis Market. There is a sizable patient population with hematological disorders & a high prevalence of chronic diseases in North American nations. Additionally, these countries’ increasing per capita consumer spending has led to a notable surge in health investments. The people of the region are choosing more sophisticated medicines as a result of the rising economy, which is driving North America Apheresis Market growth.

Along with other blood disorders, sickle cell disease & leukemia are also steadily rising in the region. Hence, during the projected period, there would be a continued upsurge in demand for apheresis to successfully treat these disorders & lessen the issues linked to these diseases.

What Does Our Apheresis Market Research Study Entail?

• Global Halal Food Market Research Report highlights the forecast growth rate or CAGR by anticipating the market size & share.
• The market analysis puts light upon the primary industry trends, driving aspects, potential opportunities, growth challenges, and other major factors.
• Global Halal Food Market Research Report entails details about the most critical shifts in market share in the prominent regions.
• Considering the statistics & the developments by the primary market competitors, our report also strives to demonstrate the most sought-after strategies of the key players.